Skip to main content

Eupraxia Pharmaceuticals Inc(EPRX-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Eupraxia Pharmaceuticals Inc down on Wednesday (EPRX)

Automated Summaries - The Globe and Mail - Wed Apr 3, 4:02PM CDT

Eupraxia Pharmaceuticals Inc opened trading today at $4.06 and closed at $3.85. prices ranged from a low of $3.85 to a high of $4.06.

Share prices dipped -2.28 percent from the previous day's close of $3.94.

Today across North America, the TSX Composite closed -0.50% at 22075.10, the S&P 500 closed -0.72% at 5205.81, the Dow Jones Industrial Average closed -1.00% at 39170.24 and the Nasdaq Composite closed -0.95% at 16240.45.

Eupraxia Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker EPRX.

A total of 44,509 shares was traded during the session, with total trades of 88, with an average volume of 59,895 over the last 5 days.

The TSX overall saw 2,968 price advancers against 2,262 declines and 117 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.85 (April 03,2024). Moreover, the shares have eased -9.62% in 52 weeks, while they have shrunken -28.31% year-to-date.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $140.35 million on a float of 35,622 shares outstanding. Its annual EPS is $-1.53.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Based on 0.00 analysts, Eupraxia Pharmaceuticals Inc gets an average recommendation of "Strong Sell" according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe